α4β2 nicotinic acetylcholine receptors intrinsically influence body weight in mice

Varenicline enhances recognition memory via α7 nicotinic acetylcholine receptors in the medial prefrontal cortex in male mice

Previous studies postulated that chronic administration of varenicline, a partial and full agonist at α4β2 and α7 nicotinic acetylcholine receptors (nAChRs), respectively, enhances recognition memory. However, whether its acute administration is effective, on which brain region(s) it acts, and in what signaling it is involved, remain unknown. To address these issues, we conducted a novel object recognition test using male C57BL/6J mice, focusing on the medial prefrontal cortex (mPFC), a brain region associated with nicotine-induced enhancement of recognition memory. Systemic administration of varenicline before the training dose-dependently enhanced recognition memory. Intra-mPFC varenicline infusion also enhanced recognition memory, and this enhancement was blocked by intra-mPFC co-infusion of a selective α7, but not α4β2, nAChR antagonist. Consistent with this, intra-mPFC infusion of a selective α7 nAChR agonist augmented object recognition memory. Furthermore, intra-mPFC co-infusion of U-73122, a phospholipase C (PLC) inhibitor, or 2-aminoethoxydiphenylborane (2-APB), an inositol trisphosphate (IP3) receptor inhibitor, suppressed the varenicline-induced memory enhancement, suggesting that α7 nAChRs may also act as Gq-coupled metabotropic receptors. Additionally, whole-cell recordings from mPFC layer V pyramidal neurons in vitro revealed that varenicline significantly increased the summation of evoked excitatory postsynaptic potentials, and this effect was suppressed by U-73122 or 2-APB. These findings suggest that varenicline might acutely enhance recognition memory via mPFC α7 nAChR stimulation, followed by mPFC neuronal excitation, which is mediated by the activation of PLC and IP3 receptor signaling. Our study provides evidence supporting the potential repositioning of varenicline as a treatment for cognitive impairment.

Sulfoxaflor, Zn2+ and their combinations disrupt the antioxidant and osmoregulatory (Ca2+-ATPase) system in Daphnia magna

BACKGROUND

The oxidative- and osmoregulatory stress-inducing potential of binary mixtures of sulfoxaflor (SUL), a recently developed sulfoximine insecticide, and Zn²⁺ was aimed to evaluate in Daphnia magna with different exposure regimes.

METHODS

Animals were exposed to different SUL concentrations (1.25, 2.5, 10, and 25 mg/L) for 7 days. In vivo 48 h and in vitro effects of single and binary mixtures of SUL (25 and 50 mg/L) and Zn²⁺ (40 µg/L) were also determined. Furthermore, Ca²⁺-ATPase, oxidative stress biomarkers (catalase, CAT; superoxide dismutase, SOD; glutathione peroxidase, GPX; glutathione S-transferase, GST; reduced glutathione, GSH; thiobarbituric acid reactive substances, TBARS), and morphometric characteristics were measured.

RESULTS

Variable response patterns were observed due to exposure duration and regime, toxicant type, and concentration. Marked effects of SUL were observed, especially in subacute exposure, and 25 mg/L SUL concentration can be considered as a threshold level. Stimulation of GST activity was the most typical response, followed by declined SOD activity and GSH levels. GPX activity and TBARS levels responded differently depending upon the exposure type. Subacute and in vitro effects of SUL and Zn²⁺ produced similar responses except for some cases. Ca²⁺-ATPase activity was altered differently upon subchronic duration, though inhibited by in vitro SUL+Zn effect. Subchronic SUL exposure increased body weight and length up to 25 mg/L, contrary to the observed decrease at higher concentrations.

CONCLUSIONS

Single and binary mixtures of SUL and Zn²⁺ caused damage to the antioxidant and osmoregulatory system due to their oxidative potential on cellular targets (biomarkers). The current data emphasized that investigating the SUL toxicity with the Zn²⁺ combination based on the multi-biomarker approach is essential in the realistic evaluation of SUL toxicity in toxicological research.